Building
Superintelligence
for Predictive and Reprogrammable Medicine
"We design AI agents that predict disease paths and invent reprogramming strategies to restore healthy cellular states and tackle ageing processes."
Mission
CellRewire is creating the superintelligence that learns how to predict and reprogram life at the cellular level, transforming medicine from reactive treatment to predictive, reprogrammable interventions.
RewireOS
Operating System For Predictive and Reprogrammable Medicine
Cell-DRL™ Agent (patented): Deep-reinforcement learning agent that reasons over single-cell genomics to generate unseen intermediate states and minimal molecular “switches.”
Autonomous Wet-Lab Loops: Validate and refine AI in real time; closing the AI →Lab feedback loo
Predict → Reprogram → Validate
Predict disease as a “movie,” reconstructing unseen intermediate states that govern progression.
Reprogram using Cell-DRL™ Agent to propose minimal gene/perturbation sets that drive cells toward healthy targets.
Validate in vitro with assays and closed-loop iteration.
First Indications
Cardiac Reprogramming (MI):
Fibroblast → Cardiomyocyte (RewireMI, CR-101).
Parkinson’s Disease:
Astrocyte → Dopaminergic neuron (RewirePD, NR-201).
Type 1 Diabetes:
Endocrine/α-cell → β-cell (RewireBeta, MT-301).
In-Silico and In-Vitro Validations
From AI Predictions to Therapies
We license our AI platform and advance a focused pipeline (3 Diseases × 9 Drugs) through in-vitro and in-vivo milestones toward clinical translation.
Do you have any question?
Feel free to contact us anytime.
United States
9276 Scranton Rd Suite 500,
San Diego, CA 92121,
United States
Germany
Nikola-Tesla-Straße 1,
69124 Heidelberg,
Germany
Egypt
B01, New Business Park, Mivida,
5th Settlement, New Cairo 1,
4760121 Cairo,
Egypt
Contact us: amahmoud@cellrewire.com
Copyright © 2026 - by CellRewire LLC